You are here

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, March 18, 2021 - 12:00
Conditions:   Pulmonary Fibrosis;   Interstitial Lung Disease;   Covid19
Intervention:   Biological: MON002
Sponsors:   Guy's and St Thomas' NHS Foundation Trust;   King's College London
Posted: Monday, March 15, 2021 - 12:00
Conditions:   Covid19;   Novel Coronavirus Pneumonia;   Acute Respiratory Distress Syndrome
Interventions:   Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8);   Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8);   Drug: MSC-exosomes delivered intravenously every other day (8:8:8)
Sponsor:   AVEM HealthCare
Not yet recruiting
Posted: Wednesday, February 3, 2021 - 12:00
Conditions:   Acute Respiratory Distress Syndrome;   Covid19
Intervention:   Biological: T regulatory cells
Sponsor:   Stanford University
Not yet recruiting
Posted: Wednesday, January 20, 2021 - 12:00
Conditions:   Covid19;   Sars-CoV-2 Infection;   ARDS, Human;   Severe covid19
Interventions:   Combination Product: autologous activated platelet-rich plasma;   Drug: Avigan
Sponsors:   Hayandra Peduli Foundation;   Koja Regional Public Hospital
Posted: Monday, November 16, 2020 - 12:00
Conditions:   ARDS, Human;   Covid19
Interventions:   Biological: Longeveron Mesenchymal Stem Cells (LMSCs);   Other: Placebo
Sponsor:   Longeveron LLC
Posted: Wednesday, November 11, 2020 - 12:00
Condition:   COVID19 ARDS
Interventions:   Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells;   Biological: Placebo
Sponsor:   Central Hospital, Nancy, France
Not yet recruiting
Posted: Monday, October 26, 2020 - 12:00
Condition:   Acute Respiratory Distress Syndrome
Interventions:   Biological: low dose hMSC-Exos;   Biological: medium dose hMSC-Exos;   Biological: high dose hMSC-Exos;   Biological: Dosage 1of hMSC-Exos;   Biological: Dosage 2 of hMSC-Exos;   Biological: No hMSC-derived exosomes
Sponsors:   Ruijin Hospital;   Cellular Biomedicine Group Ltd.
Not yet recruiting
Posted: Friday, October 9, 2020 - 12:00
Condition:   Respiratory Distress Syndrome, Adult
Intervention:   Drug: agenT-797
Sponsor:   AgenTus Therapeutics, Inc.
Posted: Wednesday, October 7, 2020 - 12:00
Condition:   Corona Virus Infection
Intervention:   Biological: T memory cells and NK cells
Sponsors:   Instituto de Investigación Hospital Universitario La Paz;   Universidad Autonoma de Madrid;   Universidad Miguel Hernandez de Elche;   Asociación Instituto de Investigación Sanitaria BioCruces;   Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Posted: Thursday, September 3, 2020 - 12:00
Conditions:   Covid19;   Acute Respiratory Distress Syndrome
Intervention:   Biological: CYP-001
Sponsors:   Cynata Therapeutics Limited;   Cerebral Palsy Alliance Research Institute